Tag
The post discusses the potential of bioelectricity in future medicine, highlighting Dr. Michael Levin's research on reprogramming cells through electrical signals and suggesting that next-generation pharmaceutical companies will focus on this field.
Biotech startup Vivodyne claims current AI models lack sufficient human tissue data for effective drug discovery and has developed robotic labs called HIVE to generate this data, aiming to improve preclinical testing for diseases like cancer.